Orrstown Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $506K | Buy |
1,137
+160
| +16% | +$71.2K | 0.11% | 93 |
|
|
2025
Q1 | $474K | Buy |
977
+30
| +3% | +$14.5K | 0.11% | 91 |
|
|
2024
Q4 | $381K | Buy |
947
+248
| +35% | +$99.9K | 0.1% | 103 |
|
|
2024
Q3 | $325K | Buy |
699
+95
| +16% | +$44.2K | 0.1% | 110 |
|
|
2024
Q2 | $283K | Buy |
604
+88
| +17% | +$41.2K | 0.15% | 71 |
|
|
2024
Q1 | $216K | Buy |
+516
| New | +$216K | 0.12% | 79 |
|